Recombinant Anti-FcγRI × Anti-LPA Bispecific Antibody (Tandem Diabody) (CAT#: TAND-L054)

Recombinant Anti-FcγRI × Anti-LPA Bispecific Antibody (Tandem Diabody) is a bispecific fusion protein with four binding sites, two of which bind to antigens of one kind of cells and the other two to the other kind of cells. It was designed for the treatment of thrombus.


Specific Inquiry
  • Size:
  • Conjugation:
  • Datasheet
  • MSDS
  • COA

Specifications

  • Target
  • FcγRI & LPA
  • Type
  • Tandem Diabody
  • Species Reactivity
  • Human
  • Target 1
  • FcγRI
  • Host Species 1
  • Mouse
  • Target 2
  • LPA
  • Host Species 2
  • Mouse
  • Application
  • FuncS, Promising therapeutic agent
  • Related Disease
  • Thrombus

Target

  • Target 1
  • FcγRI
  • Alternative Names
  • CD64; FCRI; CD64A; IGFR1
  • Target 2
  • LPA
  • Alternative Names
  • LP; AK38; APOA

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAND-L054. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare